- $31.57m
- $184.66m
- $2.69m
Brief: Cibus Q2 Revenue USD 933 Thousand
Cibus Inc expected to post a loss of 69 cents a share - Earnings Preview
Cibus Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: The U.S. Food And Drug Administration Completes Review Of Cibus’ Altered Lignin Alfalfa
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
U.S. STOCKS ON THE MOVE-Owens & Minor ,Scinai , Vermilion Energy
U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker Barrel
Bio-agriculture firm Cibus tumbles on deep-discounted stock sale
Bio-agriculture firm Cibus tumbles on planned stock offering
Cibus Inc reports results for the quarter ended March 31 - Earnings Summary
Cibus Inc expected to post a loss of 66 cents a share - Earnings Preview
Cibus Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Cibus Reports Fourth Quarter Financial Results And Provides Business Update
Cibus Inc expected to post a loss of 75 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Capital One Financial, Netflix, Regeneron Pharmaceuticals
Brief: Cibus, Albaugh And Rtdc Company Affirm Collaboration To Enable Commercialization Of Cibus’ First Gene Edited Weed Management Solution
Brief: Cibus And Biographica Announce Collaboration Using Artificial Intelligence To Advance Disease Resistance In Canola And Oilseed Rape
Brief: Cibus Achieves Additional Milestone For Gene Edits For Sclerotinia Resistance In Canola
Cibus Inc reports results for the quarter ended September 30 - Earnings Summary